Drug Shortage Report for MINT-OLANZAPINE ODT

Last updated on 2018-07-25 History
Report ID 35467
Drug Identification Number 02436965
Brand name MINT-OLANZAPINE ODT
Common or Proper name Olanzapine ODT
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 30 Count Blisters
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-01-09
Actual start date 2018-01-09
Estimated end date 2018-06-29
Actual end date 2018-07-24
Shortage status Resolved
Updated date 2018-07-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2018-07-25 English Compare
v11 2018-07-24 French Compare
v10 2018-07-24 English Compare
v9 2018-06-01 French Compare
v8 2018-06-01 English Compare
v7 2018-05-15 French Compare
v6 2018-05-15 English Compare
v5 2018-04-12 French Compare
v4 2018-04-12 English Compare
v3 2018-01-10 English Compare
v2 2018-01-09 French Compare
v1 2018-01-09 English Compare

Showing 1 to 12 of 12